Why the study?
Should the patient with non-Q-wave MI have myocardial revascularization or strictly medical therapy?
Should the patient with non-Q-wave MI have myocardial revascularization or strictly medical therapy?
Highlights the prognostic paradox of non-Q-wave MI, which carries high risks of reinfarction and late mortality, emphasizing the need to determine the optimal strategy between revascularization and medical therapy.
May warrant intensified post-MI surveillance; leaves open whether revascularization or medical therapy is optimal.
It is now clear that non-Q-wave MI, whose incidence appears to be rising, carries an increased risk of reinfarction and recurrent ischemia. Indeed, non-Q-wave late mortality may equal or exceed that of its Q-wave counterpart. The management question: Should the patient with non-Q-wave MI have myocardial revascularization or strictly medical therapy?
No takes yet. Share an insight, caveat, or question.
William E. Boden (1992) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: